SecSonar.com

Haemonetics Corporation (HAE)

Haemonetics Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Haemonetics Corporation (HAE) is a Medical - Instruments & Supplies company based in US with a market capitalization of $3.1B. Revenue declined 2.0% year-over-year and the company generated $260.4M in free cash flow. This page tracks HAE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3.66K employees · IPO May 10, 1991

Valuation

Valuation & price

$56.29 · as of May 17, 2026 · -35.4% vs 52w high

27.4

P/E ratio

Latest-FY diluted EPS

3.84

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$87.16$67.66$48.17Jul 25Dec 25Jul 26Jul 7, 25$75.13Jul 9, 25$77.52Jul 11, 25$75.52Jul 15, 25$74.62Jul 17, 25$73.45Jul 21, 25$73.77Jul 23, 25$74.56Jul 25, 25$75.20Jul 29, 25$75.54Jul 31, 25$74.04Aug 4, 25$76.30Aug 6, 25$75.77Aug 11, 25$52.47Aug 13, 25$53.88Aug 15, 25$53.74Aug 19, 25$54.30Aug 21, 25$53.98Aug 25, 25$55.23Aug 27, 25$55.03Aug 29, 25$54.54Sep 3, 25$53.28Sep 5, 25$54.38Sep 9, 25$54.24Sep 11, 25$53.48Sep 16, 25$51.02Sep 18, 25$51.15Sep 22, 25$51.18Sep 24, 25$50.61Sep 26, 25$48.17Sep 30, 25$48.74Oct 2, 25$48.90Oct 6, 25$49.55Oct 8, 25$50.98Oct 10, 25$48.85Oct 14, 25$49.76Oct 16, 25$49.77Oct 21, 25$51.19Oct 23, 25$51.35Oct 27, 25$51.21Oct 29, 25$49.44Oct 31, 25$50.01Nov 4, 25$50.38Nov 6, 25$67.11Nov 10, 25$70.48Nov 12, 25$73.12Nov 14, 25$73.49Nov 18, 25$74.40Nov 20, 25$75.12Nov 25, 25$80.63Nov 28, 25$81.35Dec 2, 25$80.79Dec 4, 25$83.81Dec 8, 25$83.21Dec 10, 25$87.16Dec 12, 25$83.49Dec 16, 25$81.11Dec 18, 25$79.90Dec 22, 25$80.34Dec 24, 25$80.01Dec 29, 25$80.53Jan 2, 26$79.98Jan 6, 26$82.77Jan 8, 26$84.04Jan 12, 26$82.92Jan 14, 26$75.73Jan 16, 26$72.17Jan 21, 26$70.11Jan 23, 26$68.82Jan 27, 26$67.87Jan 29, 26$65.96Feb 2, 26$65.78Feb 4, 26$65.95Feb 9, 26$57.69Feb 11, 26$57.50Feb 13, 26$57.76Feb 18, 26$60.63Feb 20, 26$61.19Feb 24, 26$61.68Feb 26, 26$62.24Mar 2, 26$63.88Mar 4, 26$64.67Mar 6, 26$64.13Mar 10, 26$62.85Mar 12, 26$59.49Mar 17, 26$60.05Mar 19, 26$58.90Mar 23, 26$58.46Mar 25, 26$55.93Mar 27, 26$54.04Mar 31, 26$56.36Apr 2, 26$56.83Apr 7, 26$59.56Apr 9, 26$58.42Apr 13, 26$59.27Apr 15, 26$61.95Apr 17, 26$61.62Apr 22, 26$61.13Apr 24, 26$59.93Apr 28, 26$59.84Apr 30, 26$60.09May 4, 26$55.32May 6, 26$52.67May 8, 26$55.12May 12, 26$54.01May 14, 26$57.12May 18, 26$57.28May 20, 26$59.56May 22, 26$65.49May 28, 26$67.04Jun 1, 26$67.22Jun 3, 26$65.88Jun 5, 26$71.28Jun 9, 26$78.71Jun 11, 26$79.84Jun 15, 26$76.91Jun 17, 26$72.73Jun 22, 26$72.53Jun 24, 26$72.87Jun 26, 26$77.29Jul 2, 26$75.07
$47.6752-week range$87.16
Loading valuation history…

Fundamentals

Key fundamentals

$3.1B

Market cap

-2.0%

Revenue growth (YoY)

55.7%

Gross margin

$260.4M

Free cash flow (USD)

$979.1M

Net debt

-6.3%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2026

FY 2017$886.1MFY 2018$903.9MFY 2019$967.6MFY 2020$988.5MFY 2021$870.5MFY 2022$993.2MFY 2023$1.2BFY 2024$1.3BFY 2025$1.4BFY 2026$1.3B
$886.1M$1.3B

Free cash flow by year

2017 → 2026

FY 2017$83.6MFY 2018$145.6MFY 2019$40.3MFY 2020$109.5MFY 2021$71.8MFY 2022$75.8MFY 2023$162.9MFY 2024$115.5MFY 2025$142.4MFY 2026$260.4M
$83.6M$260.4M

Gross margin by year

2022 → 2026

FY 202253.4%FY 202353.3%FY 202454.4%FY 202557.2%FY 202655.7%
53.4%55.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-K filed May 20, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventSegment Structure UpdateJun 5, 2026Filing
  • Annual report10-K FiledMay 20, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • 8-K eventDirector DepartureMay 1, 2026Filing

Questions

Frequently asked questions

What is Haemonetics Corporation's market cap?

Haemonetics Corporation (HAE) has a market capitalization of $3.1B.

What is HAE's P/E ratio?

HAE trades at a price-to-earnings ratio of 27.4, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is HAE's price-to-book (P/B) ratio?

HAE trades at 3.84 times book value per share.

Are insiders buying HAE stock?

SEC Form 4 filings show no open-market insider buys at Haemonetics Corporation in the last 90 days (0 sells).

Same arena

Related companies in Medical - Instruments & Supplies

WRBY

Warby Parker Inc.

$3B

ICUI

ICU Medical, Inc.

$3.4B

MMSI

Merit Medical Systems, Inc.

$3.8B

LMAT

LeMaitre Vascular, Inc.

$2.2B

XRAY

DENTSPLY SIRONA Inc.

$2.1B

NVCR

NovoCure Limited

$2B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.